Hongbo Lu

CIK 1767584 · last filed 2026-05-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.33M

Companies

5

Total Filings

25

Lifetime Open-Market Net

$28.23M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARWR Director 52,012 $74.52 $3.88M -$145.3K 4 2026-05-14
ZBIO Director 426,736 $19.80 $8.45M $7.65M 6 2026-04-02
Terns Pharmaceuticals, Inc. (TERN) Delisted Director 476,190 $52.95 $25.21M $19.64M 11 2025-06-12
AVEDRO INC (AVDR) Delisted Director $24.25 $0 3 2019-11-25
Turning Point Therapeutics, Inc. (TPTX) Delisted Director 1,727,550 $76.01 $131.31M $1.08M 1 2019-04-24

Recent Filings · Page 3 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-02-26 Terns Pharmaceuticals, Inc. (TERN) Delisted Grant (A) $0 EDGAR
2019-11-25 AVEDRO INC (AVDR) Delisted Disp (D) $0 EDGAR
2019-06-18 AVEDRO INC (AVDR) Delisted Grant (A) $0 EDGAR
2019-04-24 Turning Point Therapeutics, Inc. (TPTX) Delisted Mixed +1,727,550 $1.08M EDGAR
2019-02-19 AVEDRO INC (AVDR) Delisted Grant (A) $0 EDGAR
Showing 2125 of 25
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.